Product Information
MARAVIROC 300 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $6.2876 per EA under NDC 31722058060. Its NADAC has been published 123 times since Apr 17, 2024.
FDA first approved this application on Feb 7, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722058060
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
MARAVIROCApproval Type
Generic (ANDA)
FDA Application
ANDA203347FDA Approved
2/7/2022
TE Code
AB
On Market Since
2/6/2022
Pharmacological Classes
Price Statistics
The NADAC for MARAVIROC 300 MG TABLET has been published 123 times since Apr 17, 2024, and over the history we have for it it has declined 69.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.2876 per EA |
|---|---|
| All-time high | $20.8330 (Jun 12, 2024) |
| All-time low | $6.2876 (Aug 19, 2026) |
| 52-week high | $14.4863 |
| 52-week low | $6.2876 |
| Median price | $16.7694 |
| Average price | $14.8815 |
| Largest weekly change | -22.9% (Sep 17, 2025) |
| Weeks tracked | 123 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MARAVIROC 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MARAVIROC 300 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $6.2876 per EA (NDC 31722058060), effective Aug 19, 2026.
How has the price of MARAVIROC 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for MARAVIROC 300 MG TABLET has declined 69.5%. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for MARAVIROC 300 MG TABLET?
Since Apr 17, 2024, the NADAC for MARAVIROC 300 MG TABLET has ranged from a low of $6.2876 (Aug 19, 2026) to a high of $20.8330 (Jun 12, 2024), with a median of $16.7694 per EA.
Are there cheaper alternatives to MARAVIROC 300 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MARAVIROC 300 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures MARAVIROC 300 MG TABLET?
MARAVIROC 300 MG TABLET (NDC 31722058060) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.